Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity

• Masahiro Hiratsuka ,

  Contributed equally to this work with: Masahiro Hiratsuka, Hiroshi Yamashita, Takahiro Mori

  * E-mail: mhira@m.tohoku.ac.jp

  Affiliation Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

  ⨯
• Hiroshi Yamashita ,

  Contributed equally to this work with: Masahiro Hiratsuka, Hiroshi Yamashita, Takahiro Mori

  Affiliation Department of Surgery, Iwate Prefectural Chubu Hospital, Kitakami, Japan

  ⨯
• Fumika Akai,

  Affiliation Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

  ⨯
• Hiroki Hosono,

  Affiliation Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

  ⨯
• Eiji Hishinuma,

  Affiliation Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

  ⨯
• Noriyasu Hirasawa,

  Affiliation Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

  ⨯
• Takahiro Mori

  Contributed equally to this work with: Masahiro Hiratsuka, Hiroshi Yamashita, Takahiro Mori

  Affiliation Graduate School of Medicine, Tohoku University, Sendai, Japan

  ⨯